Huakun Huang
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathway" 134 (February) (2021) 111155.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 26, 2024
The bidirectional effects of APPswe on the osteogenic differentiation of MSCs in bone homeostasis by regulating Notch signaling.
Journal: Genes & diseases
Published: January 20, 2024
Corrigendum to ‟Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways" [Chem. Biol. Interact. 365 (2022) 110068].
Journal: Chemico-biological interactions
Published: April 07, 2023
Echinatin inhibits the growth and metastasis of human osteosarcoma cells through Wnt/β-catenin and p38 signaling pathways.
Journal: Pharmacological research
Published: December 26, 2022
TAZ promotes osteogenic differentiation of mesenchymal stem cells line C3H10T1/2, murine multi-lineage cells lines C2C12, and MEFs induced by BMP9.
Journal: Cell death discovery
Published: November 15, 2022
Nitazoxanide inhibits osteosarcoma cells growth and metastasis by suppressing AKT/mTOR and Wnt/β-catenin signaling pathways.
Journal: Biological chemistry
Published: March 25, 2022
Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways.
Journal: Chemico-biological interactions
Published: November 23, 2021
Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 12, 2020
Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
Journal: Drug design, development and therapy
Published: August 16, 2020
Lycorine inhibits cell proliferation, migration and invasion, and primarily exerts in vitro cytostatic effects in human colorectal cancer via activating the ROS/p38 and AKT signaling pathways.
Journal: Oncology reports
Published: June 26, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026